No phaseRecruiting
Spyral InSight Study
Spyral InSight Early Clinical Feasibility Study
- Sponsor
- Medtronic Vascular (Industry)
- Enrollment
- 19 planned
- Conditions
- Hypertension; Vascular Diseases; Cardiovascular Diseases
- Interventions
- Renal nerve stimulation
- Ages
- adults, older adults
- Registry
- NCT07013929
Full record on ClinicalTrials.gov
From the registry
The purpose of the Spyral InSight Early Clinical Feasibility Study is to characterize the physiological response to renal nerve stimulation (RNS) in humans prior to and post renal denervation.
Primary outcomes
- All-cause mortality
- End-stage renal disease
- Myocardial infarction
- Incidence of stroke
History
Study completion expected
Primary completion expected
Last registry update
Registered
Started